Analysts Offer Predictions for Dr. Reddy's Laboratories Limited's Q3 2024 Earnings (NYSE:RDY)

Dr. Reddy’s Laboratories Limited (NYSE:RDY – Free Report) – Equities research analysts at Zacks Research lifted their Q3 2024 earnings per share (EPS) estimates for shares of Dr. Reddy’s Laboratories in a research report issued on Tuesday, July 25th. Zacks Research analyst E. Bagri now expects that the company will earn $0.77 per share for […]

Related Keywords

Reddy Laboratorie ,Sanfordc Bernstein ,Zacks Research ,Qtron Investments ,James Investment Research Inc ,Reddy Laboratories Limited ,Sequoia Financial Advisors ,Reddy Laboratories ,Group Ltd ,Barclays ,Laboratories Limited ,Free Report ,Get Free Report ,Wealth Management ,Financial Advisors ,Investment Research ,Global Generics ,Pharmaceutical Services ,Active Ingredients ,Laboratories Daily ,Dr Reddys Laboratories ,Nyse Rdy ,Ardy ,Medical ,Earnings Estimates ,